Company Profile
- Stock Code
- INSM
- ISIN Code
- US4576693075
- Currency
- US Dollar (USD)
- IPO Date
- 2000-06-01

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung...